Surmodics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SRDX research report →
About the company
Surmodics, Inc. , together with its affiliates, specializes in providing advanced surface modification solutions tailored for intravascular medical devices. Additionally, the company supplies specialized chemical components essential for in vitro diagnostic immunoassay tests and microarrays.
- CEO
- Gary R. Maharaj
- IPO
- 1998
- Employees
- 389
- HQ
- Eden Prairie, MN, US
Price Chart
- Market Cap
- $614.51M
- P/E
- -58.88
- P/S
- 10.66
- P/B
- 5.51
- EV/EBITDA
- -67.10
- Div Yield
- 0.00%
- Gross Margin
- 71.54%
- Op Margin
- -16.05%
- Net Margin
- -18.26%
- ROE
- -9.50%
- ROIC
- -6.02%
- Revenue
- $126.08M · -4.91%
- Net Income
- $-11,542,000 · -651.43%
- EPS
- $-0.82 · -645.45%
- Op Income
- $-5,645,000
- FCF YoY
- -142.71%
- 52W High
- $43.00
- 52W Low
- $25.87
- 50D MA
- $30.68
- 200D MA
- $31.12
- Beta
- 1.39
- Avg Volume
- 435.96K
Get TickerSpark's AI analysis on SRDX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 19, 25 | OLSON CHARLES W | sell | 20,101 |
| Nov 19, 25 | OLSON CHARLES W | sell | 800 |
| Nov 19, 25 | OLSON CHARLES W | sell | 18,337 |
| Nov 19, 25 | OLSON CHARLES W | sell | 10,653 |
| Nov 19, 25 | OLSON CHARLES W | sell | 13,579 |
| Nov 19, 25 | OLSON CHARLES W | sell | 17,883 |
| Nov 19, 25 | OLSON CHARLES W | sell | 19,243 |
| Nov 19, 25 | Manders John D. | sell | 1,862 |
| Nov 19, 25 | Manders John D. | sell | 4,810 |
| Nov 19, 25 | Manders John D. | sell | 8,155 |
Our SRDX coverage
Recent articles, reports, and earnings notes.
No research on SRDX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SRDX report →Similar companies
Peers in the same neighborhood.